Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Neutrophil CD64 and Monocyte HLA-DR Markers in the Dignosis of Neonatal Sepsis

NCT05985174 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05985174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05985174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Neutrophil CD64 and Monocyte HLA-DR Markers in the Dignosis of Neonatal Sepsis
Lead sponsor
Sohag University
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2023
Completion date
August 1, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis